Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 26, 2018
Selexis SA and Hoba Therapeutics announced they have entered into an agreement to advance the development of Hoba’s clinical candidate HB-086 for peripheral neuropathic pain.
read more
Wednesday, September 26, 2018
WuXi Biologics and I-Mab Biopharma jointly announced that I-Mab has expanded strategic collaboration with WuXi Biologics and licensed proprietary WuXiBody Platform to develop three bispecific antibodies.
read more
Tuesday, September 25, 2018
Cambrex announced that it is to establish a center of excellence for API clinical supply and process development at its site in High Point, North Carolina.
read more
Tuesday, September 25, 2018
AGC will be establishing a cGMP-compatible mammalian cell culture facility at its Chiba Plant designed to take on contracts for antibody biopharmaceutical development and production
read more
Tuesday, September 25, 2018
Cantrell Drug Company, a 503B Registered Outsourcing Facility, announced that the company has received final approval from the FDA to begin producing and shipping product.
read more
Tuesday, September 25, 2018
Elpro has announced the release of its new temperature monitoring device, the LIBERO ITS.
read more
Tuesday, September 25, 2018
Anaeropharma announced Astellas have signed a collaborative research agreement concerning the creation of novel anti-tumor drugs that utilizes characteristic features of Bifidobacterium longum.
read more
Monday, September 24, 2018
GeneCentric Therapeutics announced that the company has acquired an exclusive license from the UNC at Chapel Hill to technology for subtyping Pancreatic Ductal Adenocarcinoma.
read more
Monday, September 24, 2018
ZappRx announced its partnership with Dunn Meadow, a national specialty pharmacy, headquartered in New Jersey.
read more
Monday, September 24, 2018
ABEC announced the shipment of Emergent BioSolutions’ CSR dual purpose single-use systems for large scale 750L microbial fermentation and 500L mammalian cell culture.
read more
Monday, September 24, 2018
Cerveau announced a research collaboration agreement with Ionis for use of [F-18]MK-6240, an investigational imaging agent to be used in PET scans for assessing the status and progression of NFTs in the brain.
read more
Monday, September 24, 2018
McKesson Medical-Surgical has signed an exclusive agreement with ILÚM Health Solutions that provides innovative technology and services to support infectious disease management, to serve the U.S. community hospital market.
read more
Monday, September 24, 2018
A new cell based profiling service for drug discovery from Reaction Biology Corporation (RBC) and Promega Corporation will allow more researchers to better prioritize compounds earlier.
read more
Friday, September 21, 2018
The FDA is finalizing two guidance documents and making available one draft guidance to help ensure that prescription drug products are identified and traced properly as they move through the supply chain in compliance with federal law.
read more
Friday, September 21, 2018
The FDA has issued a warning letter to Pharmaceutical Laboratories and Consultants regarding several violations at the Illinois-based lab, including the presence of a microbrewery in its drug testing area.
read more